LONDON, England – April 4, 2016 – NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that it will participate in BritSpine 2016 held April 6-8, 2016 at Nottingham Conference Centre, in Nottingham, England. NuVasive’s participation at BritSpine will include numerous education workshops and exhibitions of the Company’s procedurally-integrated spine surgery offerings. This will include the first-time introduction of NuVasive’s Integrated Global Alignment (iGA) platform to the U.K. market, representing a significant advancement in the historical approach to spine surgery by integrating procedural technology and tools into one platform to help address proper alignment.
Paul Kosters, NuVasive’s Vice President of Europe, Middle East and Africa, said, “We are pleased to participate at BritSpine 2016 as NuVasive deepens our commitment to providing surgeons throughout the U.K. with access to our highly differentiated, minimally invasive spinal solutions. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive’s highly differentiated solutions increase the value of care by delivering both an improved patient experience and better economics for customers and the healthcare system. At BritSpine, we are eager to showcase our latest game-changing iGA technology that centers on achieving the integrated global alignment of the spine, which has proven to be the most correlative element to successful, long-term surgical outcomes. This combination of industry-leading procedural solutions will be a driving force as we continue to expand in the U.K. and partner with surgeons to help them deliver superior surgical outcomes.”
This biennial scientific congress of the United Kingdom Spine Societies Board Ltd (UKSSB) represents a gathering of delegates from three British spine organizations, including the Society for Back Pain Research (SBPR), the British Scoliosis Society (BSS) and the British Association of Spine Surgeons (BASS). The object of UKSSB is to promote the development of treatment of spinal disorders through education, study and research for the benefit of the public and the United Kingdom.
NuVasive’s BritSpine Exhibit Stand (#47) Details
Surgeon support and collaboration will be the cornerstone to NuVasive’s presence at BritSpine as the Company exhibits products and procedural innovations that align closely with surgeon needs. This year, NuVasive will provide a particular emphasis on showcasing NuVasive’s iGA platform through an enhanced exhibit stand experience and new digital assets designed to better engage BritSpine attendees in more clinically relevant and compelling ways that build better understanding around the value of the Company’s procedurally-integrated solutions. In addition, the Company will also feature XLIF ACR with integrated Bendini® Spinal Rod Bending System to correct sagittal alignment, Reline® posterior fixation technology providing integrated Open and MAS® procedural solutions, and Precept® MAS pedicle screw system designed to address simple to the most complex pathologies.
Surgeon education will also be a central focus through NuVasive’s lunch workshops and product demonstrations, in addition to other learning opportunities. The following lunch workshops will take place in the Hooley Room at the Nottingham Conference Centre:
Wednesday, April 6, 2016
- 12:45 to 13:45 – Global Spinal Alignment: It Matters presented by Dr. Pedro Berjano, Mr. Stewart Tucker
Thursday, April 7, 2016
- 13:15 to 14:00 – Global Spinal Alignment: It Matters presented by Mr. Stewart Tucker
Integrated Global Alignment (iGA)
Integrated Global Alignment is a proprietary, procedurally-integrated digital platform enabling precise spinal column alignment. The multi-product suite of spine surgical devices forms a complete procedural platform and operating philosophy that centers on the critical importance of proper alignment. The launch of the iGA platform includes a suite of alignment focused offerings, such as the introduction of next generation fixation, anterior and posterior implants, updated neuromonitoring and computer-assisted rod bending and surgical planning technology. It is this combination of procedurally-based technologies that are unique to NuVasive and designed to enhance clinical outcomes by increasing the predictability of achieving global alignment in spinal procedures.
About NuVasive
NuVasive is an innovative global medical device company that is transforming spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. NuVasive has emerged from a small startup to become the #3 player in the $9 billion global spine market and remains focused on market share-taking strategies as the Company continues on its path to become the industry’s leading spine company. NuVasive offers a comprehensive spine portfolio of more than 90 unique products developed to improve spine surgery and patient outcomes. The Company’s principal procedural solution is its Maximum Access Surgery, or MAS®, platform for lateral spine fusion. MAS was designed to provide safe, reproducible, and clinically proven outcomes, and is a highly differentiated solution with fully integrated neuromonitoring, customizable exposure, and a broad offering of application-specific implants and fixation devices designed to address a variety of pathologies.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive’s results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company’s surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive’s products (including the iGA™ platform), the Company’s ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive’s news releases and periodic filings with the Securities and Exchange Commission. NuVasive’s public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
# #
Investor/Media Contact:
Stacy Roughan
NuVasive, Inc.
1-858-909-1812
[email protected]